Included in the portfolio of the fund: RVC Biofund
Link to website: http://www.nbioservice.com/
Year of inclusion in the portfolio: 2013
Investment Status: Seeding and initial
Economic Sector: Biotechnology, Medicine and Health Care
Direction of modernization: Medical Equipment and Pharmaceuticals
City: Saint Petersburg

National BioService is the first Russian non-dedicated commercial research bio-bank, the official partner of ISBER. Since 2014, National BioService forms a part of biological and medical technologies claster of "Skolkovo" fund. NBS was established to be instrumental in developing the infrastructure of biomedical research in Russia and integrating into international activities, aimed at improving human healthcare and developing personalized medicine.

Fundamental activities of the company include collection, processing, storage and analysis of biological samples necessary for design of new medical drugs and diagnostic systems. The bio bank cooperates with more than 90 medical and research centers working at the territory of the Russian federation.

To date, National BioService is Russia's only designer and manufacturer of tissular micro-arrays (TMA) used for testing and developing of therapeutic and diagnostic antibodies. The company performs its activities in accordance with high international standards and principles of ethics, transparency and mutually beneficial cooperation with clients and partners.